ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
2,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
4,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
6,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7,1,Hypoplastic left heart syndrome,Cardiac hypoplasias congenital,Cardiac and vascular disorders congenital,Cong,Y
8,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
8,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
9,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
10,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
10,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
10,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
10,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
11,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
12,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
12,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12,4,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
12,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
13,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
14,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
14,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
15,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
16,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
16,2,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
16,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
17,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
17,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
18,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
18,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
18,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
19,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
20,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
21,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
22,1,Abnormal product of conception,Abortion related conditions and complications,Abortions and stillbirth,Preg,N
23,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
24,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
25,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
26,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
27,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
28,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
29,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
30,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
31,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
31,2,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
32,1,Deafness,Hearing losses,Hearing disorders,Ear,N
33,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
34,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
35,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
35,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
35,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
35,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,1,Headache,Headaches NEC,Headaches,Nerv,N
36,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
38,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
39,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
40,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
40,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
40,3,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
41,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
42,1,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
43,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
44,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
45,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
45,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
46,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
47,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
48,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
49,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
50,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
51,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
51,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
52,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
53,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
54,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
55,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
55,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
56,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
57,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
58,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
59,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
59,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
60,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
61,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
62,1,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
63,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
63,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
65,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
66,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
66,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
68,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
69,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
70,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
70,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
70,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
70,4,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
71,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
71,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
72,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
72,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
72,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
72,4,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
72,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
72,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
73,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
74,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
74,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
74,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
75,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
77,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
78,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
79,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
80,1,Primary biliary cholangitis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
81,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
82,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
83,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
83,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
83,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
84,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
84,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
84,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,1,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
85,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
86,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
86,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
86,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
87,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
87,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
87,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
87,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
87,5,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
88,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
88,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
89,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
89,2,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
89,3,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
90,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
90,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
90,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
91,1,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
91,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
91,3,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
91,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
91,5,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
91,6,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
92,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
92,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
92,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
92,4,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
93,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
94,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
95,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
95,3,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
96,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
97,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
98,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
99,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
100,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
101,1,Abortion missed,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
102,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
102,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
103,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
103,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
104,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
104,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
105,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
106,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
107,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
108,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
109,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
110,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
111,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
111,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
111,3,Headache,Headaches NEC,Headaches,Nerv,N
112,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
113,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
114,1,Spermatogenesis abnormal,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
115,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
116,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
116,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
117,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
117,2,Headache,Headaches NEC,Headaches,Nerv,N
117,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
118,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
119,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
120,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
121,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
123,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
124,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
125,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
125,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
126,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
127,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
128,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
128,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
129,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
130,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
130,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
131,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
131,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
131,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
131,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
131,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
132,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
132,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
132,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
133,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
133,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
133,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
134,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
135,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
136,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
137,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
138,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
139,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
140,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
140,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
140,3,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
140,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
141,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
141,2,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
142,1,Headache,Headaches NEC,Headaches,Nerv,N
142,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
143,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
143,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
143,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
143,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
144,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
145,1,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
146,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
146,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
147,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
148,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
149,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
150,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
151,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
151,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
152,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
152,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
153,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
154,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
154,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
155,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
156,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
157,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
158,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
159,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
160,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
161,1,Spermatogenesis abnormal,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
162,1,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
163,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
164,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
164,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
165,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
166,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
167,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
168,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
169,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
170,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
170,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
170,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
171,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
172,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
173,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
174,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
175,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
176,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
177,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
178,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
179,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
180,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
181,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
181,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
182,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
182,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
183,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
183,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
183,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
183,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
184,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
184,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
184,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
184,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
185,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
186,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
187,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
188,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
189,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
189,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
190,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
191,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
191,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
192,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
192,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
193,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
194,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
195,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
196,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
196,2,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
197,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
197,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
197,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
197,4,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
197,5,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
197,6,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
197,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
197,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
198,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
199,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
200,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
201,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
202,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
202,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
203,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
203,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
203,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
204,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
204,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
205,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
205,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
206,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
206,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
207,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
207,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
208,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
209,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
210,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
210,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
211,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
211,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
212,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
213,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
214,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
215,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
215,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
216,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
217,1,Headache,Headaches NEC,Headaches,Nerv,N
218,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
218,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
219,2,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
220,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
220,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
220,3,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
221,1,Tachycardia paroxysmal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
222,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
223,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
223,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
224,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
225,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
225,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
225,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
225,4,Headache,Headaches NEC,Headaches,Nerv,N
225,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
225,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
225,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
225,8,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
225,9,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
225,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
226,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
226,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
226,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
226,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
227,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
227,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
228,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
229,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
230,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
230,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
231,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
231,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
232,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
233,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
233,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
233,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
234,1,Rhinophyma,Rosaceas,Skin appendage conditions,Skin,N
235,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
236,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
237,1,Eczema eyelids,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
238,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
239,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
240,1,Excessive cerumen production,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
241,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
241,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
241,3,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
241,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
241,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
241,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
241,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
241,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
241,9,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
241,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
242,1,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
243,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
243,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
244,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
244,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
245,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
245,2,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
246,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
246,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
246,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
246,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
246,5,Product counterfeit,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
246,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
246,7,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
247,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
248,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
248,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
248,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
248,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
248,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
248,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
248,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
249,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
249,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
249,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
249,4,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
249,5,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
249,6,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
249,7,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
249,8,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
249,9,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
249,10,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
249,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
249,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
249,13,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
249,14,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
249,15,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
249,16,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
249,17,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
249,18,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
249,19,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
249,20,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
250,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
250,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
250,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
250,4,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
250,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
250,6,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
251,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
251,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
251,3,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
252,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
253,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
253,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
253,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
254,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
254,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
254,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
254,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
254,5,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
254,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
254,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
254,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
254,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
254,10,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
254,11,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
254,12,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
254,13,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
255,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
255,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
255,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
255,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
255,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
256,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
256,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
256,3,Acne,Acnes,Skin appendage conditions,Skin,N
256,4,Acrochordon,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
256,5,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
256,6,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
256,7,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
256,8,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
256,9,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
256,10,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
256,11,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
256,12,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
256,13,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
256,14,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
256,15,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
256,16,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
256,17,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
256,18,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
256,19,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
256,20,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
256,21,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
256,22,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
256,23,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
256,24,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
256,25,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
256,26,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
256,27,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
256,28,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
256,29,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
256,30,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
256,31,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
256,32,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
256,33,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
256,34,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
256,35,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
256,36,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
256,37,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
256,38,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
256,39,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
256,40,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
256,41,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
256,42,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
256,43,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
257,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
257,2,Headache,Headaches NEC,Headaches,Nerv,N
257,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
258,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
258,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
258,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
259,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
259,2,Headache,Headaches NEC,Headaches,Nerv,N
260,1,Acne,Acnes,Skin appendage conditions,Skin,N
260,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
260,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
260,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
261,1,Acne,Acnes,Skin appendage conditions,Skin,N
261,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
262,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
262,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
263,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
263,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
264,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
264,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
265,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
266,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
266,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
266,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
266,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
266,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
266,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
268,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
268,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
268,3,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
268,4,Dental restoration failure,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
268,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
268,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
268,7,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
268,8,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
268,9,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
268,10,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
268,11,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
268,12,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,13,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
268,14,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
268,15,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
268,16,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
268,17,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
268,18,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
269,1,Headache,Headaches NEC,Headaches,Nerv,N
270,1,Dermatitis papillaris capillitii,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
270,2,Pseudofolliculitis,Pilar disorders NEC,Skin appendage conditions,Skin,N
271,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
271,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
271,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
271,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
272,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
273,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
273,2,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
274,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
274,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
275,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
275,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
276,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
277,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
277,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
277,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
277,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
278,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
278,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
278,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
279,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
279,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
279,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
280,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
280,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
281,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
281,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
281,3,Dark circles under eyes,Ocular disorders NEC,Eye disorders NEC,Eye,N
281,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
281,5,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
281,6,Headache,Headaches NEC,Headaches,Nerv,N
282,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
283,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
283,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
284,1,Headache,Headaches NEC,Headaches,Nerv,N
285,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
285,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
285,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
286,1,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
286,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
287,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
287,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
287,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
287,4,Kidney congestion,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
287,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
287,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
287,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
288,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
288,2,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
288,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
289,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
289,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
289,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
290,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
291,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
291,2,Headache,Headaches NEC,Headaches,Nerv,N
291,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
291,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
291,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
291,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
291,7,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
291,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
291,9,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
291,10,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
292,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
292,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
292,3,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
292,4,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
292,5,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
292,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
292,7,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
292,8,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
292,9,Headache,Headaches NEC,Headaches,Nerv,N
292,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
292,11,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
292,12,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
292,13,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
292,14,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
292,15,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
292,16,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
292,17,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
292,18,Sensation of blood flow,Feelings and sensations NEC,General system disorders NEC,Genrl,N
292,19,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
292,20,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
292,21,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
292,22,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
292,23,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
292,24,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
293,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
293,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
293,3,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
293,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
293,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
293,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
293,7,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
293,8,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
294,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
294,2,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
294,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
294,4,Disability,Disability issues,Lifestyle issues,SocCi,N
294,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
294,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
294,7,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
294,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
294,9,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
294,10,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
294,11,Sensation of blood flow,Feelings and sensations NEC,General system disorders NEC,Genrl,N
294,12,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
294,13,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
295,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
295,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
295,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
296,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
296,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
297,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
297,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
297,3,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
297,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
297,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
297,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
297,7,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
297,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
297,9,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
297,10,Laziness,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
297,11,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
297,12,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
297,13,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
297,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
297,15,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
297,16,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
297,17,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
297,18,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
297,19,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
297,20,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
297,21,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
298,1,Deafness,Hearing losses,Hearing disorders,Ear,N
298,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
299,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
300,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
300,2,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
300,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
300,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
301,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
302,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
302,2,Headache,Headaches NEC,Headaches,Nerv,N
302,3,Nonspecific reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
303,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
303,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
303,3,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
303,4,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
304,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
304,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
304,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
305,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
305,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
305,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
306,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
306,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
306,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
306,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
307,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
307,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
307,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
307,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
307,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
307,6,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
307,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
308,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
308,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
309,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
309,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
309,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
309,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
310,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
310,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
310,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
310,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
310,5,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
310,6,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
311,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
311,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
311,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
311,4,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
311,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
312,1,Lymph node pain,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
312,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
312,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
313,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
313,2,Dermal cyst,Skin cysts and polyps,Cutaneous neoplasms benign,Skin,N
313,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
314,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
315,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
316,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
316,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
316,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
317,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
317,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
318,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
318,2,Exposure via body fluid,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
318,3,Ovulation disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
319,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
320,1,Administration site discharge,Administration site reactions NEC,Administration site reactions,Genrl,N
320,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
320,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
320,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
320,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
321,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
321,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
321,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
321,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
322,1,Disturbance in sexual arousal,Sexual arousal disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
322,2,Emotional poverty,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
322,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
322,4,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
322,5,Orgasmic sensation decreased,Orgasmic disorders and disturbances,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
322,6,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
323,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
324,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
325,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
325,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
325,3,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
325,4,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
325,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
325,6,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
325,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
325,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
326,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
326,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
326,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
327,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
327,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
327,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
327,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
327,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
327,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
327,7,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
327,8,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
327,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
327,10,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
327,11,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
327,12,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
327,13,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
327,14,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
327,15,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
327,16,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
327,17,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
327,18,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
327,19,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
327,20,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
327,21,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
327,22,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
328,1,Application site mass,Application site reactions,Administration site reactions,Genrl,N
328,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
328,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
328,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
329,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
330,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
330,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
331,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
331,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
331,3,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
332,1,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
332,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
332,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
332,4,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
332,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
332,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
332,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
332,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
333,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
333,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
333,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
333,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
333,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
334,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
335,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
335,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
336,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
336,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
336,3,Semen viscosity decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
336,4,Semen volume decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
337,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
337,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
337,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
337,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
337,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
338,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
338,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
338,3,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
339,1,Blood testosterone increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
339,2,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
339,3,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
340,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
341,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
342,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
342,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
343,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
343,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
344,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
345,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
345,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
345,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
346,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
346,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
346,3,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
346,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
346,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
347,1,Headache,Headaches NEC,Headaches,Nerv,N
348,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
349,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
349,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
349,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
350,1,Headache,Headaches NEC,Headaches,Nerv,N
351,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
352,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
352,2,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
353,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
353,2,Application site wound,Application site reactions,Administration site reactions,Genrl,N
353,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
353,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
353,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
354,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
355,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
355,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
355,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
356,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
356,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
357,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
357,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
357,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
358,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
358,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
359,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
359,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
359,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
360,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
360,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
361,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
361,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
362,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
362,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
362,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
362,4,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
362,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
362,6,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
363,1,Headache,Headaches NEC,Headaches,Nerv,N
363,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
364,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
364,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
364,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
364,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
364,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
364,6,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
364,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
365,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
365,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
366,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
366,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
367,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
368,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
369,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
369,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
370,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
370,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
371,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
371,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
372,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
372,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
372,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
372,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
372,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
372,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
372,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
373,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
373,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
373,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
374,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
375,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
375,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
376,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
377,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
378,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
378,2,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
378,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
379,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
380,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
381,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
381,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
381,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
382,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
383,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
383,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
383,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
383,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
383,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
383,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
384,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
384,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
385,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
386,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
386,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
387,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
387,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
388,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
389,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
389,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
390,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
390,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
391,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
391,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
392,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
392,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
393,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
393,2,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
394,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
394,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
395,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
396,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
396,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
397,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
398,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
398,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
399,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
399,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
400,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
400,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
401,1,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
402,1,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
402,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
403,1,Headache,Headaches NEC,Headaches,Nerv,N
404,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
404,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
404,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
404,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
405,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
405,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
405,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
406,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
407,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
407,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
407,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
407,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
408,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
409,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
410,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
411,1,Lid sulcus deepened,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
411,2,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
412,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
413,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
413,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
414,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
414,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
415,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
415,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
416,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
416,2,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
417,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
417,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
418,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
418,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
419,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
420,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
420,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
421,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
421,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
422,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
422,2,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
423,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
424,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
424,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
425,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
425,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
425,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
426,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
427,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
427,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
428,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
428,2,Headache,Headaches NEC,Headaches,Nerv,N
429,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
429,2,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
430,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
431,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
431,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
432,1,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
432,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
433,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
434,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
434,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
435,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
435,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
436,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
437,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
438,1,Headache,Headaches NEC,Headaches,Nerv,N
439,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
439,2,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
440,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
440,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
440,3,Headache,Headaches NEC,Headaches,Nerv,N
441,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
442,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
443,1,Headache,Headaches NEC,Headaches,Nerv,N
444,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
444,2,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
444,3,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
444,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
444,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
445,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
446,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
447,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
447,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
448,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
449,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
450,1,Headache,Headaches NEC,Headaches,Nerv,N
451,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
452,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
453,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
453,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
454,1,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
454,2,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
454,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
454,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
454,5,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
455,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
455,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
455,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
455,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
456,1,Headache,Headaches NEC,Headaches,Nerv,N
457,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
458,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
458,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
459,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
460,1,Headache,Headaches NEC,Headaches,Nerv,N
461,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
462,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
463,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
464,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
465,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
466,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
467,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
468,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
469,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
470,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
470,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
471,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
472,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
473,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
474,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
475,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
476,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
477,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
477,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
477,3,Sticky skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
478,1,Headache,Headaches NEC,Headaches,Nerv,N
479,1,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
479,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
480,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
480,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
481,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
481,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
482,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
482,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
483,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
484,1,Deformity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
484,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
484,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
484,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
484,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
484,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
485,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
486,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
487,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
487,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
488,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
489,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
490,1,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
490,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
490,3,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
490,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
491,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
492,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
493,1,Acne,Acnes,Skin appendage conditions,Skin,N
493,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
494,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
494,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
495,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
495,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
496,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
497,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
498,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
498,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
498,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
499,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
499,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
499,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
500,1,Headache,Headaches NEC,Headaches,Nerv,N
501,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
502,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
503,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
504,1,Headache,Headaches NEC,Headaches,Nerv,N
504,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
504,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
505,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
505,2,Application site scab,Application site reactions,Administration site reactions,Genrl,N
506,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
506,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
507,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
508,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
509,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
510,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
511,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
512,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
513,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
514,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
515,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
516,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
517,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
518,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
519,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
520,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
521,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
522,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
522,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
523,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
524,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
525,1,Headache,Headaches NEC,Headaches,Nerv,N
526,1,Headache,Headaches NEC,Headaches,Nerv,N
527,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
527,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
528,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
528,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
528,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
529,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
530,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
530,2,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
530,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
531,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
532,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
533,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
534,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
535,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
535,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
536,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
536,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
536,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
536,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
537,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
537,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
537,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
537,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
538,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
539,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
540,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
541,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
542,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
542,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
543,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
544,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
544,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
544,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
545,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
545,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
545,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
546,1,Headache,Headaches NEC,Headaches,Nerv,N
547,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
547,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
547,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
548,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
548,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
548,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
548,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
549,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
549,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
549,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
549,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
550,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
550,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
550,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
550,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
551,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
551,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
551,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
551,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
552,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
552,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
552,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
553,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
553,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
553,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
553,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
554,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
554,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
554,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
555,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
555,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
555,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
555,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
555,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
556,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
557,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
558,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
558,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
558,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
559,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
560,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
561,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
561,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
561,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
561,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
562,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
563,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
564,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
565,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
565,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
566,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
567,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
567,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
568,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
568,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
569,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
569,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
570,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
571,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
572,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
573,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
574,1,Headache,Headaches NEC,Headaches,Nerv,N
575,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
576,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
576,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
577,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
578,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
579,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
580,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
581,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
582,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
583,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
584,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
585,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
586,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
587,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
588,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
589,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
590,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
591,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
592,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
593,1,Application site hyperaesthesia,Application site reactions,Administration site reactions,Genrl,N
593,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
593,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
593,4,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
593,5,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
594,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
595,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
595,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
596,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
597,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
598,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
599,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
599,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
600,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
601,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
602,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
603,1,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
603,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
603,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
604,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
605,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
605,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
606,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
606,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
607,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
607,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
608,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
609,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
610,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
611,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
611,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
612,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
612,2,Application site burn,Application site reactions,Administration site reactions,Genrl,N
612,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
612,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
612,5,Application site scab,Application site reactions,Administration site reactions,Genrl,N
612,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
613,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
614,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
615,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
615,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
615,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
616,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
617,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
618,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
619,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
620,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
621,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
622,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
623,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
624,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
625,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
626,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
626,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
626,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
626,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
626,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
627,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
628,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
629,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
630,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
631,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
631,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
631,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
631,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
631,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
632,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
633,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
633,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
633,3,Product packaging difficult to open,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
634,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
634,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
635,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
636,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
636,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
636,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
637,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
637,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
638,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
638,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
638,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
638,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
638,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
638,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
638,7,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
639,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
639,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
639,3,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
639,4,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
640,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
641,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
641,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
642,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
643,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
644,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
645,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
645,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
646,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
647,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
647,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
647,3,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
648,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
648,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
648,3,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
648,4,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
649,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
650,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
651,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
652,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
653,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
653,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
653,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
654,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
655,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
655,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
656,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
656,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
657,1,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
658,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
659,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
660,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
660,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
661,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
661,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
662,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
662,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
663,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
663,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
663,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
664,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
665,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
666,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
667,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
667,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
668,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
669,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
669,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
669,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
669,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
669,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
670,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
670,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
670,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
670,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
671,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
672,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
672,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
672,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
673,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
674,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
674,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
674,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
675,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
676,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
676,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
677,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
678,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
678,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
679,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
679,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
679,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
680,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
681,1,Acne,Acnes,Skin appendage conditions,Skin,N
681,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
681,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
681,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
682,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
682,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
682,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
683,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
684,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
685,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
686,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
687,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
688,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
689,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
690,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
691,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
692,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
693,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
694,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
694,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
695,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
696,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
697,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
697,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
697,3,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
697,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
697,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
698,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
699,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
700,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
701,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
702,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
703,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
704,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
705,1,Headache,Headaches NEC,Headaches,Nerv,N
706,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
707,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
708,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
709,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
710,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
711,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
711,2,Headache,Headaches NEC,Headaches,Nerv,N
711,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
712,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
713,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
714,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
715,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
716,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
717,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
718,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
719,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
719,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
720,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
721,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
722,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
723,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
724,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
725,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
726,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
726,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
727,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
728,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
729,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
729,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
730,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
730,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
731,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
731,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
732,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
733,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
734,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
735,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
735,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
735,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
735,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
735,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
735,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
736,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
737,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
738,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
739,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
739,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
739,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
739,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
739,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
740,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
740,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
740,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
740,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
740,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
740,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
741,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
741,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
741,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
741,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
742,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
742,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
742,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
743,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
744,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
745,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
746,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
747,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
748,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
749,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
750,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
750,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
750,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
751,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
751,2,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
751,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
751,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
751,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
752,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
752,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
752,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
753,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
754,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
755,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
755,2,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
755,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
755,4,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
756,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
756,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
757,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
757,2,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
758,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
758,2,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
758,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
758,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
758,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
758,6,Application site scab,Application site reactions,Administration site reactions,Genrl,N
758,7,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
759,1,Dark circles under eyes,Ocular disorders NEC,Eye disorders NEC,Eye,N
759,2,Facial wasting,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
759,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
759,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
759,5,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
760,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
760,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
761,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
762,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
763,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
764,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
764,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
765,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
765,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
765,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
765,4,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
765,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
765,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
765,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
766,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
767,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
767,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
768,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
768,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
768,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
768,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
769,1,Headache,Headaches NEC,Headaches,Nerv,N
770,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
771,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
772,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
773,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
774,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
775,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
776,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
777,1,Headache,Headaches NEC,Headaches,Nerv,N
778,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
779,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
780,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
781,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
782,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
783,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
784,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
785,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
785,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
786,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
787,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
787,2,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
788,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
789,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
790,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
791,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
792,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
792,2,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
793,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
793,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
793,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
794,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
795,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
795,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
795,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
796,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
797,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
798,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
799,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
800,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
801,1,Headache,Headaches NEC,Headaches,Nerv,N
802,1,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
803,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
804,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
805,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
806,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
807,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
808,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
809,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
809,2,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
810,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
810,2,Headache,Headaches NEC,Headaches,Nerv,N
811,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
811,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
811,3,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
812,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
813,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
814,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
814,2,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
815,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
815,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
816,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
816,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
817,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
817,2,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
817,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
818,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
818,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
818,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
819,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
819,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
820,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
821,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
822,1,Deafness,Hearing losses,Hearing disorders,Ear,N
822,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
823,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
823,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
823,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
824,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
825,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
825,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
825,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
826,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
827,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
827,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
827,3,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
828,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
829,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
830,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
831,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
832,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
832,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
833,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
834,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
835,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
836,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
837,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
838,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
838,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
839,1,Dark circles under eyes,Ocular disorders NEC,Eye disorders NEC,Eye,N
839,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
839,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
840,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
840,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
841,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
842,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
842,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
843,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
843,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
843,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
844,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
844,2,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
845,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
846,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
847,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
848,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
848,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
848,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
848,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
849,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
849,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
849,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
849,4,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
850,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
850,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
851,1,Headache,Headaches NEC,Headaches,Nerv,N
852,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
